Bionanomagnetic carrier delivers 100% of doxorubicin under cancerous conditions, suggesting effective controlled release.
A bionanomagnetic carrier comprising chitosan/g-C 3 N 5 /CaFe 2 O 4 was synthesized for the targeted delivery and controlled release of doxorubicin (DOX). The results showed the release of 100% of DOX under simulated cancerous cell conditions (pH 5.6).
No takes yet. Share an insight, caveat, or question.
Varmazyar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: